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Background: The optimal timing of second-stage palliation after Norwood opera-
tions remains undefined. Advantages of early cavopulmonary anastomosis are early
elimination of volume load and shortening the high-risk interstage period. Potential
disadvantages include severe cyanosis, prolonged pleural drainage and hospitaliza-
tion, and excess mortality. We reviewed our recent experience to evaluate the safety
of early cavopulmonary anastomosis.
Methods: Eighty-five consecutive patients undergoing post–Norwood operation
cavopulmonary anastomosis were divided into group I (cavopulmonary anastomosis
at 4 months; n  33) and group II (cavopulmonary anastomosis at 4 months; n
 52). Groups were compared for age; size; early and late mortality; preoperative,
initial postoperative, and discharge oxygen saturation; and duration of mechanical
ventilation, intensive care unit stay, pleural drainage, and hospitalization.
Results: Group I patients were younger than group II patients (94  21 days vs 165
 44 days, respectively; P  .001) and smaller (4.8  0.8 kg vs 5.8  0.9 kg; P
 .001). The preoperative oxygen saturation was not different (group I, 75% 
10%; group II, 78%  8%; P  .142). The oxygen saturation was lower immedi-
ately after surgery in group I compared with group II (75%  7% vs 81%  7%,
respectively; P  .001) but not by discharge (group I, 79%  4%; group II, 80%
 4%). Younger patients were ventilated longer (62  86 hours vs 19  42 hours;
P  .001), in the intensive care unit longer (130  111 hours vs 104  94 hours;
P  .049), hospitalized longer (12.5  11.5 days vs 10.3  14.8 days; P  .012),
and required longer pleural drainage (106 45 hours vs 104 93 hours; P .046).
Hospital survival was 100% in both groups. Actuarial survival to 12 months was
96%  4% for group I and 96%  3% for group II.
Conclusions: Early cavopulmonary anastomosis after the Norwood operation is safe.
Younger patients are more cyanotic initially after surgery and have a longer duration of
mechanical ventilation, pleural drainage, intensive care unit stay, and hospitalization.
Contemporary management of children with univentricular heartsand aortic arch obstruction includes an initial modified Norwoodoperation, followed months later by conversion to a superior venacaval source of pulmonary blood flow and, finally, by 2 to 3 yearsof age, the addition of inferior caval blood to pulmonary inflow toachieve the complete Fontan physiology. Conversion of the source
of pulmonary blood from a systemic pulmonary shunt to a cavopulmonary anasto-
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mosis is desirable for several theoretical reasons1,2: to
change from an inefficient parallel circulation to a more
efficient series circulation, to reduce the effects of chronic
volume loading on the single ventricle,3 to protect the
pulmonary vasculature from systemic arterial pressure, to
increase systemic diastolic blood pressure, to normalize
coronary blood flow patterns,4 and to end the period of
vulnerability to sudden death, which is known to extend
from stage I to stage II palliation.5-7 Despite these potential
benefits of conversion to cavopulmonary physiology, opti-
mal timing of the second-stage operation remains unsettled.
Potential disadvantages of very early operation include ex-
cessive cyanosis, prolonged and complicated hospital stays,
and excess mortality.1,2,8-10 We have recently instituted an
aggressive home monitoring program for patients after Nor-
wood operation that has led in some cases to earlier perfor-
mance of stage II palliation.7 Even in patients without
events detected by home monitoring, we have tended to
perform second-stage palliation at an earlier age. To deter-
mine the effect of earlier cavopulmonary anastomosis, we
compared a group of children who underwent unusually
early operation with a contemporaneous group who under-
went operation at a more conventional age.
Patients and Methods
Patient Population
The medical records of 85 consecutive patients undergoing cavo-
pulmonary anastomosis after an initial Norwood procedure be-
tween January 1998 and February 2003 at the Children’s Hospital
of Wisconsin were reviewed. These patients were derived from an
original cohort of 86 consecutive patients undergoing Norwood
operations, 1 of whom died of mesenteric ischemia at 114 days of
age. All children underwent unilateral or bilateral bidirectional
cavopulmonary anastomosis (CPA), as well as any other indicated
procedures, such as atrioventricular valve repair, aortic arch re-
construction, or pulmonary arterioplasty. By institutional policy,
recurrent arch obstruction was not addressed at the time of pre-
CPA cardiac catheterization, but instead was relieved surgically at
the time of CPA. To determine the effect of age at operation on
outcome, the patients were divided into those younger than 4
months at the time of CPA (group I; n  33) and those older than
4 months at operation (group II; n  52). Timing of operation was
at the discretion of the attending cardiologist and surgeon. In group
I, 24 patients were followed up in the home monitoring protocol,
14 of whom had an event detected (cyanosis, weight loss, or poor
weight gain) that led to intervention but not necessarily to early
operation. In group II, 22 patients had home monitoring, of whom
7 had an event detected. Demographic information, cardiac anat-
omy, associated procedures, duration of ventilation, intensive care
unit (ICU) stay, duration of chest tube drainage, length of hospi-
talization, and oxygen saturation (SaO2) data at various time points
were recorded. Hemodynamic data from cardiac catheterization
and on arrival in the ICU after surgery were also tabulated.
Permission for the study was obtained from the Institutional Re-
view Board of the Children’s Hospital of Wisconsin.
Cardiac Catheterization
Most patients underwent preoperative cardiac catheterization to
assess candidacy for second-stage operation and to identify any
anatomic abnormalities necessitating intervention. Hemodynamic
variables recorded included pulmonary artery pressure, ventricular
end-diastolic pressure, SaO2, and superior vena caval oxygen sat-
uration. Because of difficulties with vascular access or significant
shunt narrowing, not all data were available for all patients. The
timing of catheterization was variable relative to operation, but in
elective situations, the 2 were typically not performed during the
same hospitalization.
Operative Technique and Management
The operations were performed with moderately hypothermic
(28°C-32°C) cardiopulmonary bypass and bicaval venous cannu-
lation. Cold blood cardioplegic arrest was used if intracardiac
procedures were performed. A brief period of deep hypothermic
circulatory arrest was used if aortic arch reconstruction was nec-
essary. After termination of cardiopulmonary bypass, modified
ultrafiltration was used in all patients.
Cavopulmonary anastomoses were constructed in an end-to-
side fashion after division of the superior vena cava and oversew-
ing of the cardiac end of the vessel. The azygous vein was
routinely divided (as was the hemiazygous vein in the case of
bilateral superior vena cavae) unless the patient had an interrupted
inferior vena cava. All anastomoses were accomplished with run-
ning 7-0 polypropylene sutures. If aortic arch narrowing had been
identified by preoperative catheterization, the narrowed region was
enlarged with cryopreserved allograft pulmonary artery, as were
any pulmonary arterial stenoses. Bilateral pleural drains and 2
mediastinal drains were placed in all patients.
Anesthesia management typically consisted of a balanced in-
haled opioid technique that used fentanyl-equivalent dosing at 5 to
25 g/kg and isoflurane at 1% to 2%. At the discretion of the
attending anesthesiologist, regional anesthesia was additionally
used (caudal block with 1 mL/kg of 0.25% bupivacaine with
epinephrine 1:200,000 plus 30 to 100 g/kg of epidural morphine).
Most children were managed with the intention of immediate
postoperative extubation. Intraoperative and immediate postoper-
ative hemodynamic monitoring routinely consisted of a superior
vena caval catheter (via the jugular or subclavian vein), a direct
atrial catheter, and a radial or femoral arterial catheter. All patients
received a milrinone loading dose (50 g/kg) and an infusion (0.5
g · kg1 · min1) and low-dose dopamine (3 to 5 g · kg1 ·
min1). Some patients also received infusions of epinephrine 0.02
to 0.1 g · kg1 · min1 as needed. All children received aprotinin
as previously described.11,12
ICU Management
Patients who did not require mechanical ventilation after surgery
were maintained on supplemental oxygen at to keep SaO2 greater
than 75%. Patients who required mechanical ventilation were
managed with pressure-controlled ventilation at the lowest possi-
ble mean airway pressure. After recovery from neuromuscular
blockade and sedation, mechanical ventilation was withdrawn
when patients were breathing spontaneously and comfortably on
fractional inspired oxygen concentrations less than 40%, with SaO2
greater than 70%, and with acceptable hemodynamic parameters.
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Atrial pressure monitoring catheters were routinely removed on
the first postoperative day. Some patients received low-dose hep-
arin infusions (10 g · kg1 · h1) while superior vena caval
catheters were in place, and these catheters were typically removed
on the third or fourth postoperative day. Inotropic medications
were decreased and discontinued on the basis of supervising phy-
sician judgment. Oral feeding was commenced on the first post-
operative day or the first day after the discontinuation of mechan-
ical ventilation. Mediastinal and pleural drains were removed at
the discretion of the attending surgeon, but not typically until the
patient had demonstrated 24 hours of successful enteral feeding
without an increase in pleural drainage.
Oxygen Saturation
Continuous arterial pulse oximetry was used in all patients. SaO2
was recorded at several time points for comparison: during cardiac
catheterization, on admission to the hospital, on admission to the
ICU after CPA, and just before hospital discharge.
Statistical Analysis
All data are expressed as group means  SD. Median values and
quartiles are reported where appropriate. Normally distributed
clinical parameters were compared with t tests. The Fisher exact
test was used for binary variables. Nonnormally distributed data
were compared by Mann-Whitney test. Because the cutoff age of
4 months was relatively arbitrary, correlation analysis was used to
examine the potential relationship between age and certain specific
outcome variables (duration of mechanical ventilation, duration of
chest drainage, length of ICU stay, and length of hospital stay).
Kaplan-Meier analysis was used to determine actuarial survival
with log-rank comparison of groups. SPSS 11.5 (SPSS Inc, Chi-
cago, Ill) was used to perform the analyses.
Results
Patient Characteristics
By definition, the patients in group I were younger than
those in group II (94  21 days vs 165  44 days, respec-
tively; P .001) and smaller (4.8 0.8 kg vs 5.8 0.9 kg;
P  .001). The youngest patient who underwent CPA was
42 days old. Patient diagnoses are shown in Table 1 and
were distributed similarly in the 2 groups. Most patients had
classic hypoplastic left heart syndrome with aortic atresia or
aortic stenosis. Approximately 20% of the patients in each
group had other forms of univentricular cardiac anatomy
and aortic obstruction.
Preoperative Cardiac Catheterization
Preoperative cardiac catheterization data were available for
78 patients. Mean pulmonary artery pressures, obtained by
crossing the systemic to pulmonary artery shunt, were 14 
5 mm Hg for group I and 15  3 mm Hg for group II (P 
.251). Likewise, ventricular end-diastolic pressures were
not different between groups (group I, 13  4 mm Hg;
group II, 12  3 mm Hg; P  .197). SaO2 values during
catheterization were not different between groups (group I,
76%  6%; group II, 78%  7%; P  .142), nor were
superior vena caval oxygen saturations (group I, 55% 
11%; group II, 55%  12%; P  .876).
Operative Details
A significant number of children required additional surgi-
cal procedures at the time of CPA (Table 2). In the younger
group, 40% required simultaneous procedures, and in the
older group, 25% had additional intervention (P  .227). In
both groups, most additional procedures were aortic arch
reconstructions to treat recurrent aortic arch obstruction. No
other procedure was performed in more than 2 patients in
either group. The duration of cardiopulmonary bypass was
nearly identical for the 2 groups (group I, 81  28 minutes;
group II, 83  32 minutes; P  .806). Among the patients
who required aortic crossclamping, the mean clamp time
was identical and very short in each group (9  15 min-
utes); this reflects the infrequent need for simultaneous
intracardiac repair.
Mortality, Mechanical Ventilation, Intensive Care
Course, and Hospital Course
Operative and hospital survival were 100% in both groups.
Actuarial survival to 1 year of age by Kaplan-Meier analysis
was 96%  4% in the younger group and 96%  3% in the
older group (P  .962). There was 1 death 3 months after






HLHS, aortic atresia 21 (64%) 28 (54%)
HLHS, aortic stenosis 6 (18%) 5 (10%)
HLHS, VSD 0 8 (15%)
TA, TGA, CoA 3 (9%) 2 (4%)
DILV, TGA, CoA 2 (6%) 3 (6%)
Other 1 (3%) 6 (11%)
HLHS, Hypoplastic left heart syndrome; VSD, ventricular septal defect; TA,
tricuspid atresia; TGA, transposition of the great arteries; CoA, coarctation
of aorta; DILV, double-inlet left ventricle.






None 20 (61%) 39 (75%)
Aortic arch reconstruction 8 (24%) 7 (13%)
Aortic arch reconstruction and
pulmonary arterioplasty
1 (3%) 0
Pulmonary arterioplasty 2 (6%) 1 (2%)
Atrioventricular valvuloplasty 1 (3%) 2 (4%)
Ligate left superior vena cava 0 2 (4%)
Pulmonary or systemic venoplasty 1 (3%) 1 (2%)
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CPA in group I (overwhelming enterovirus infection), and
in group II there were 2 late deaths (1 suddenly 4.5 months
after surgery, without autopsy, and 1 of overwhelming
cytomegalovirus infection 2.5 months after surgery).
The likelihood of successful immediate postoperative
extubation in the operating room was 13% in the younger
group and 31% in the older group (P  .068). Initial ICU
hemodynamic data were very similar: superior vena caval
pressure was 14  5 mm Hg in the younger patients and 15
 5 mm Hg in the older group (P  .777). Likewise, atrial
pressures were essentially the same in the 2 groups (6  4
mm Hg in group I vs 5  4 in group II; P  .11). The data
for duration of ventilation, length of ICU stay, length of
hospitalization, and duration of pleural drainage are pre-
sented in Table 3. Because these times were very prolonged
in a few patients in each group, median values for each
parameter are also presented. Correlation analysis showed
age to be significantly negatively related to the duration of
mechanical ventilation (R  0.4; P  .001), the duration
of ICU stay (R  0.3; P  .01), and the length of hospital
stay (R  0.3; P  .01), but not to the duration of chest
tube drainage (R  0.2; P  .06).
Oxygenation
The SaO2 values recorded on admission to the hospital were
similar (group I, 75%  10%; group II, 78%  8%; P 
TABLE 3. Details of hospitalization
Variable
Group I (n  33) Group II (n  52)
P valueMean  SD
Median
(25th, 75th




Mechanical ventilation (h) 62 86 23 (9.2, 95) 19 42 7 (0, 19) .001
ICU stay (h) 130 111 93 (69, 127) 104 94 70 (47, 117) .049
Pleural drainage (h) 106 45 91 (71, 134) 104 93 71 (63, 103) .046
Hospitalization (d) 12.5 11.5 8 (6, 13) 10.3 14.8 6 (5, 9) .012
Groups were compared by Mann-Whitney test for nonnormally distributed data. ICU, Intensive care unit.
Figure 1. Oxygen saturations at various time points are shown. The groups were statistically significantly different
only at ICU admission.
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.106). On arrival in the ICU after surgery, the younger group
had significantly lower SaO2 (group I, 75%  7%; group II,
81%  7%; P  .001). However, by the time of hospital
discharge, this difference had vanished (group I, 79% 
4%; group II, 80%  4%; P  .120). These data are shown
graphically, along with the data obtained at preoperative
cardiac catheterization, in Figure 1.
Discussion
As the care of children with congenital heart disease has
evolved, there has been a continuing trend toward earlier
intervention, on the basis of the premise that the sooner
abnormal physiology can be normalized, the better the ul-
timate outcome. The limitations of this eminently logical
principle have been both anatomic (size mismatch between
relatively large instruments, catheters, bypass circuits, and
so on) and physiologic, relating to the unique milieu of the
neonate (increased pulmonary vascular resistance, tissue
fragility, susceptibility to capillary leak syndrome, and so
on). Nonetheless, the techniques of open cardiac operation
in neonates and small infants can now be said to be well
established.
Another important concept is that if a staged approach is
necessary, then preliminary staging efforts should be
planned and performed so as to optimize ultimate outcome.
This concept is quite applicable to the management of
children with univentricular hearts managed on a Fontan
pathway, in whom staging should be performed in a fashion
that minimizes pulmonary vascular resistance and optimizes
systolic and diastolic ventricular performance. In such a
scheme, the second-stage operation also affords an oppor-
tunity to resolve any residual hemodynamic abnormalities
before Fontan completion. If achieved, the twin goals of a
low transpulmonary gradient and a compliant ventricle
functioning at minimal preload should promote the best
early and late Fontan outcome.
When applied to infants with univentricular hearts and
aortic obstruction in whom a Norwood operation has been
performed, the principles of earliest intervention and best
Fontan candidacy would suggest the earliest possible per-
formance of cavopulmonary connection. Tempering the en-
thusiasm for this approach, however, are reports in which
very young infants undergoing CPA were prone to severe
hypoxemia, pulmonary artery thrombosis, and prolonged
pleural effusions, with consequently prolonged hospitaliza-
tion.1,2,8-10 In a group of children with heterogeneous diag-
noses undergoing bidirectional cavopulmonary shunts, mul-
tiple regression analysis identified younger age as a
predictor of lower postoperative SaO2.13 In a large group of
patients undergoing second-stage operation, younger age
was associated with a higher incidence of an adverse com-
posite outcome (death and unsuitability for Fontan opera-
tion), although no specific breakpoint age could be identi-
fied.10 A 2003 report from the Congenital Heart Surgeons
Society has identified younger age at the time of operation
as a risk factor for mortality after stage II operation.14
The data from this study would support previous obser-
vations that younger patients are at greater risk for postop-
erative hypoxemia.1,2,8,9 However, the initial postoperative
SaO2 difference between groups was fairly small (75% vs
81%) and probably of minimal clinical significance. It is
worth mentioning, though, that the younger group included
a few patients with very low initial SaO2 values (in the range
of 65% to 70%), which gradually normalized over a period
of days. The reason for early hypoxemia in younger patients
is not clear but probably does not represent a baseline
difference because the preoperative saturations, both in the
cardiac catheterization laboratory and on admission to the
hospital, were not different. Preoperative hemodynamic pa-
rameters were also not different between groups, nor were
the postoperative determinations of superior vena caval
pressure or atrial pressure. Thus, the difference in initial
postoperative oxygenation cannot be explained on the basis
of a higher initial transpulmonary gradient in the younger
group. The durations of bypass time were not different
between groups either. It is likely that the initial relative
hypoxemia in younger patients simply represents an exag-
gerated susceptibility to bypass-induced injury in younger
lungs, causing an early relative alveolar hypoxia, which
resolves as the lung injury resolves. In a series of very
young patients undergoing primary bidirectional Glenn
shunts, Reddy and associates2 concluded that initial severe
hypoxemia was clearly related to cardiopulmonary bypass
because it was not seen in their patients who had the
operation without bypass. In the present study, an alterna-
tive explanation for the initial arterial oxygenation differ-
ence would be a difference in initial venous oxygen satu-
ration, reflecting a lower cardiac output in the younger
group. Unfortunately, we did not routinely measure venous
oxygen saturation and cannot confirm or refute this potential
explanation. By whatever mechanism caused, the phenom-
enon of early hypoxemia in the younger patients was tran-
sient, as demonstrated by the fact that the SaO2 values at the
time of discharge were the same in both groups.
Perhaps also explained by relatively immature bypass-
injured lungs was the difference in the requirement for
mechanical ventilation. This was best seen in the duration of
mechanical ventilation, which was much longer in the
younger group (mean duration of ventilation, 62 vs 19
hours). Because there were several children in the younger
group who required prolonged ventilation, the median
lengths of ventilation may be more representative (group I,
23 hours; group II, 7 hours), but still clearly conveyed is the
excess early ventilator dependency in the young group.
More patients in the older group were extubated in the
operating room as well (31% vs 13%), although this differ-
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ence did not achieve statistical significance. Not surpris-
ingly, the need for prolonged ventilation in the younger
patients was associated with longer ICU stays (median ICU
stay was 93 hours in group I and 70 hours in group II).
Similarly, the duration of hospitalization was longer in the
younger patients (median duration of hospitalization was 8
days in group I vs 6 days in group II). Likewise, there was
a prolongation of pleural drainage in the younger group
(median duration of pleural drainage was 91 hours in group
I vs 71 hours in group II). This last finding is slightly
surprising on the basis of essentially identical postoperative
hemodynamics in the 2 groups. The most reasonable expla-
nation is that pleural tubes were not removed until oral
feeding was commenced, which in turn was typically ap-
proximately 1 day later in the younger group because of the
longer duration of mechanical ventilation.
Postoperative low cardiac output syndrome was virtually
unknown in either group, and this was reflected in the
absence of early mortality for the entire cohort. This likely
is an indication of the inherent significant hemodynamic
benefit of ventricular unloading produced by conversion to
CPA, as well as the rare need for adjunctive intracardiac
procedures necessitating cardioplegic arrest. Intermediate
mortality was also remarkably low, with an actuarial sur-
vival to 1 year of 96% in each group. This represents 1 late
death in the younger group and 2 deaths in the older group.
Several limitations of this study must be acknowledged.
Perhaps most importantly, the study was not performed in a
prospective, randomized fashion. Furthermore, some pa-
tients underwent purely elective operation (typically the
older patients), whereas others were operated on more ur-
gently, such as those believed to have impending shunt
thrombosis as detected by our home monitoring protocol7
(more likely in the younger group). This difference would
be expected to bias in favor of worse outcome in the
younger patients, but this was not seen. An additional lim-
itation of the study is the use of end points that may be as
reflective of physician behavior as patient physiology (du-
ration of ventilation, ICU stay, hospital stay, and chest tube
drainage). That such end points are “softer” than the more
objective mortality and oxygenation data is undeniable, but
such end points are clinically informative. Furthermore, the
validity of these end points is enhanced by the retrospective
nature of the study: physician behavior could not have been
influenced in either group by a study that had not yet been
initiated.
From these data, we conclude that performance of sec-
ond-stage palliation in children who have undergone an
initial Norwood operation is as safe at less than 4 months of
age as it is at more than 4 months of age, albeit with more
resource utilization in the younger group. The major cost of
early CPA seems to be a transient relatively minor hypox-
emia and an associated requirement for mechanical venti-
lation, which in turn leads to more time in the ICU and a
longer hospital stay. In contrast, the benefits of earlier
operation, which are predominantly to be expected in rela-
tion to the Fontan completion, remain hypothetical. Contin-
ued close follow-up of this cohort will be necessary to
determine whether the suggested benefits of early second-
stage operation are in fact manifested as better early and
long-term outcomes after the Fontan operation. Finally, it is
worth noting that the absence of mortality or permanent
morbidity in the younger patients in this study implies that
the question of how young is too young remains unan-
swered. In fact, if the major determinant of timing of CPA
is the normalization of pulmonary vascular resistance,
which in children with normal hearts is nearly at its nadir by
2 weeks,15-19 it is intriguing to consider the possibility of a
rapid 2-stage approach with an initial Norwood operation
followed weeks later by conversion to a CPA.
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Discussion
Dr David Campbell (Denver, Colo). Dr Jaquiss, I want to con-
gratulate you on an excellent presentation here this morning and
also commend you and your colleagues for the fine work that you
have done. It is well known the kind of results that you have had
at the Children’s Hospital of Wisconsin Milwaukee over the last
few years with hypoplastic left heart syndrome. I’ll make com-
ments that involve information from the manuscript as well as
from your excellent presentation this morning.
This is a retrospective study that compares the outcomes of the
authors’ most recent 85 consecutive post–stage I Norwood proce-
dure infants when divided into 2 separate groups, group I having
undergone early conversion to cavopulmonary anastomosis or
cavopulmonary shunt at less than 4 months of age (33 patients) and
group II having undergone conversion at greater than 4 months of
age (52 patients). The stated recent bias of the institution, I believe,
is to perform the conversion to cavopulmonary anastomosis at an
earlier and perhaps earlier age. This brings me to my first question.
It is not entirely clear to me why the group I children came to early
conversion. Was it an individual attending physician decision,
urgent rather than elective conversion because of impending com-
plications that you mentioned, such as shunt thrombosis, or a
change in institutional bias toward earlier elective conversion
during the later part of the study? Could you clarify this if possi-
ble?
Dr Jaquiss. There was a tendency for more children in the
younger group to have impending shunt thrombosis, but it is a
general bias that we should go earlier. There was no standardized
approach.
Dr Campbell. Well, the reason that I asked this question, and
it may seem intuitively obvious at first, is that looking at the data
from your manuscript, 33% of group I patients required concom-
itant aortic arch or pulmonary artery repairs, but only 15% of
group II patients required these repairs. The group I patients are the
more recently operated-on patients, I suppose, and they were
certainly not all emergencies, yet they have a much higher inci-
dence of associated complications. Could you comment on this?
Dr Jaquiss. The group I patients, those undergoing arch revi-
sion, include a small number of patients who had aortic arch
reconstruction by using the Cryolife Synergraft pulmonary artery
patch, which we had unfortunately very bad results with in terms
of shrinkage and arch narrowing. There were very few patients, in
fact, I don’t think any, in the older group who got that, and that, I
think, accounts for the difference in concomitant arch reconstruc-
tion. Other procedures were essentially the same between groups.
Dr Campbell. The results in both groups are impressive, with
no hospital mortality in either group, and early actuarial survival
was 96% in both groups to 1 year of age, though a small price was
paid, as you pointed out. Early postoperative oxygen saturations
were lower, although they did at the time of discharge become
similar. Mechanical ventilation, ICU length of stay, pleural drain-
age, and hospitalization were longer in the group I children. My
second question is this: during the period of the study, what was
your actual interstage mortality between stage I and stage II? I
know you have commented on this in other articles, but I know you
also have presented work suggesting that the interstage mortality
can be decreased substantially by home monitoring. Could you
comment on this?
Dr Jaquiss. During the period described by the study, we had
4 interstage deaths. In the last 2 years, we have had 1 death. I can’t
remember the denominator for the entire Norwood population, but
I guess it would be 4 plus the 85.
Dr Campbell. So you have shown, I believe, that conversion to
cavopulmonary anastomosis at 4 months or less of age at your
institution is safe. The question I have is, is it necessary? To put it
differently, is it unsafe to wait? There are several reports, the most
recent by Ashburn, which I am sure you are aware of since you did
comment on this in your paper from the Congenital Heart Sur-
geons Society that was presented last year at the American Tho-
racic Society but came out in print just 1 month ago in May 2003,
which did suggest that younger age is a significant risk factor for
death after conversion of stage I Norwood children to the cavo-
pulmonary shunt.
Finally, do you have any data to suggest that the older group,
ie, those infants who had cavopulmonary conversion after 4
months of age, are experiencing a worse outcome after completion
of the Fontan, since this would be the group of patients who have
had longer periods of volume overload and a greater risk of higher
pulmonary artery resistances?
Dr Jaquiss. I don’t have any data at all to support the theory
that I advance that it is better to have surgery done earlier on the
basis of older patients having worse post-Fontan outcomes, and
like a lot of things in congenital heart surgery, unfortunately those
kinds of consequences will be seen only years or, more likely,
decades later. I think the physiologic rationale for conversion is
inarguable, and it all revolves around the question of whether there
is a mortality or morbidity risk that is significant enough to prevent
you from going earlier. The paper from the Congenital Heart
Surgeons Society is an excellent one and, like all of their papers,
is well researched with incredibly sound statistics, but it is a
multi-institutional study looking at the absolute worst subpopula-
tion of hypoplastic syndrome, those with aortic atresia, although
we had a significant percentage of those kids, and I’m not sure that
I would agree that their conclusions are generalizable into con-
temporary 2003 practice.
Dr Campbell. Yes, but I think that may be an important
concept, at least as far as I’m concerned, because there certainly
are institutions such as yours that have excellent results with this
lesion. There are others that might have been in that study, in the
multi-institutional study, that do not have as good results, so it is
not necessarily obvious that you must carry out the same kind of
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procedure at those institutions with maybe worse results. So when
you suggest that things are safe, that’s why I say it is safe at your
institution, but maybe not necessarily at others. Now having said
all this, my bias is toward early conversion to the cavopulmonary
shunt, and as more institutions move toward earlier and earlier
conversion, the question of how young is too young, I am certain,
will be answered.
Dr Winfield Wells (Los Angeles, Calif). Just 1 short question.
I am wondering if any of the patients received nitric oxide after
their bidirectional Glenn.
Dr Jaquiss. I don’t have that in the manuscript. I don’t have the
data, but I can recall anecdotally 1. The child who had the pul-
monary artery thrombosis who was a very young patient was
incredibly hypoxemic 2 days postoperatively, and among the many
things that were done as that child was taken down for angiogra-
phy was the addition of nitric oxide, which had absolutely no
benefit.
Dr Wells. Okay, but no other patients.
Dr Jaquiss. Not that I can recall.
Dr Wells. And just finally, summarizing a little bit of what has
been said, would you now be willing to restate some of the final
conclusions, that is to say, that you have proven that this is safe in
your institution but you have no evidence that it is beneficial.
Dr Jaquiss. Yes, I think that’s fair.
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